![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Chronic injection opioid use increases the systemic inflammation and T cell immune activation in virally suppressed people living with HIV - each separately HIV & Opioid Use increase immune activation, inflammation
|
|
|
AIDS 2022 July 29-Aug 4 Montreal
![0808221copy](../images/080922/080922-4/0808221copy.gif)
![0808222copy](../images/080922/080922-4/0808222copy.gif)
BACKGROUND: Opioid dependence is a major health problem in the US. Our group is investigating the immunologic consequences of opioid dependence in HIV-infected (HIV+) and HIV-uninfected (HIV-) participants. We hypothesize that virally controlled HIV+ injecting opioid users manifest immune perturbations.
METHODS: In an ongoing study, opioid users (OP+) are recruited from our needle exchange program and opioid non-users (OP-) from the clinics. Participants are grouped as HIV+OP+ (Gp1), HIV-OP+ (Gp2), HIV+OP- (Gp3), and HIV-OP- (Gp4), median age 48yr with 62% Male: 36% Female: and 2% Transgender Women. HIV+ were on ART with < HIV 200 copies/mL. Statistical methods include non-parametric group comparisons (Kruskal-Wallis), Spearman correlations and Multiple regression. (Table 1)
![0808223copy](../images/080922/080922-4/0808223copy.gif)
![0808224copy](../images/080922/080922-4/0808224copy.gif)
![0808225copy](../images/080922/080922-4/0808225copy.gif)
![0808226copy](../images/080922/080922-4/0808226copy.gif)
![0808227copy](../images/080922/080922-4/0808227copy.gif)
![0808228copy](../images/080922/080922-4/0808228copy.gif)
![0808229copy](../images/080922/080922-4/0808229copy.gif)
![08082210copy](../images/080922/080922-4/08082210copy.gif)
![08082211copy](../images/080922/080922-4/08082211copy.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|